LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Search

Aptevo Therapeutics Inc

Closed

0.4

Overview

Share price change

24h

Current

Min

0.36

Max

0.41

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Aptevo Therapeutics Inc Chart

Related News

24 Jul 2024, 23:59 UTC

Top News
Earnings

SK Hynix Second-Quarter Profit Surges on AI Chip Sales -- Update

24 Jul 2024, 23:55 UTC

Hot Stocks

Stocks to Watch: Ford, IBM, Chipotle, Warner Bros

24 Jul 2024, 23:43 UTC

Top News
Earnings

SK Hynix Delivers Another Profitable Quarter

24 Jul 2024, 23:00 UTC

Earnings

Macquarie Group 1Q Profit In Line With Expectations

24 Jul 2024, 22:16 UTC

Earnings

Wal-Mart de Mexico 2Q Net Profit Rises 9.3%

24 Jul 2024, 23:30 UTC

Market Talk

RBA Is Warned Rate Hike Would Snuff Out Confidence -- Market Talk

24 Jul 2024, 23:22 UTC

Earnings

SK Hynix 2Q Net Profit Beat FactSet-Compiled Consensus

24 Jul 2024, 23:22 UTC

Earnings

SK Hynix 2Q Oper Pft KRW5.469T Vs. Loss KRW2.882T >000660.SE

24 Jul 2024, 23:22 UTC

Earnings

SK Hynix 2Q Net KRW4.120T Vs. Loss KRW2.988T >000660.SE

24 Jul 2024, 23:21 UTC

Earnings

SK Hynix 2Q Rev KRW16.423T Vs. KRW7.306T >000660.SE

24 Jul 2024, 23:02 UTC

Top News

South Korea's Economy Slows Sharply in Second Quarter

24 Jul 2024, 22:44 UTC

Earnings

Sandfire: Debt Reduction Helped by Deferral of Motheo Capex Into FY25

24 Jul 2024, 22:43 UTC

Earnings

Sandfire 4Q Net Debt A$396 Mln, Down 18% on 3Q

24 Jul 2024, 22:43 UTC

Earnings

Sandfire 4Q Capital Expenditure A$63 Million, Up 17% on 3Q

24 Jul 2024, 22:43 UTC

Earnings

Sandfire 4Q Unaudited Underlying Ebitda A$360 Million

24 Jul 2024, 22:42 UTC

Earnings

Sandfire 4Q Unaudited Sales Revenue A$935 Million

24 Jul 2024, 22:40 UTC

Earnings

Sandfire 4Q Silver Output 1.2 Million Oz, Up 32% on 3Q

24 Jul 2024, 22:40 UTC

Earnings

Sandfire 4Q Lead Output 1,917 Tons, Up 36% on 3Q

24 Jul 2024, 22:40 UTC

Earnings

Sandfire 4Q Zinc Output 21,674 Tons, Up 17% on 3Q

24 Jul 2024, 22:39 UTC

Earnings

Sandfire Resources 4Q Copper Output 27,313 Tons, Up 9% on 3Q

24 Jul 2024, 22:25 UTC

Earnings

Lazard's Earnings Are an Early Test of CEO's Turnaround Effort -- Barrons.com

24 Jul 2024, 22:20 UTC

Earnings

Macquarie Says It Remains Well-Positioned to Deliver Superior Performance in Medium Term

24 Jul 2024, 22:20 UTC

Earnings

Macquarie Says It Continues to Maintain a Conservative Approach to Capital, Funding and Liquidity

24 Jul 2024, 22:19 UTC

Earnings

Macquarie Says It Continues to Maintain a Cautious Stance

24 Jul 2024, 22:19 UTC

Earnings

Macquarie Capital Private Credit Portfolio Over $A21.5 Billion at End-June

24 Jul 2024, 22:18 UTC

Earnings

Macquarie Capital 1Q Investment-Related Income Down on Pcp

24 Jul 2024, 22:18 UTC

Earnings

Macquarie Capital 1Q Fee and Commission Income Up on Pcp

24 Jul 2024, 22:18 UTC

Earnings

Macquarie: Commodities Unit 1Q Performance Up on Pcp

24 Jul 2024, 22:17 UTC

Earnings

Macquarie: Banking Unit Business Banking Loan Portfolio of $A16.6 Bln at End-June, Up 5% on End-March

24 Jul 2024, 22:16 UTC

Earnings

Macquarie: Banking Unit Funds on Platform of $A142.4 Billion at End-June, Flat on End-March

Peer Comparison

Price change

Aptevo Therapeutics Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

5.5 / 7.48Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

No Evidence